Jamshid Ordoni Avval
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jamshid Ordoni Avval has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Navid Shafigh
Shahid Beheshti University of Medical Sciences
4 shared publicationsMohammad Gharehbeglou
Department of Anesthesiology and Critical Care Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 shared publicationsElnaz Shafigh
Artesh University of Medical Sciences
2 shared publicationsFatemeh Roodneshin
Shahid Beheshti University of Medical Sciences
2 shared publications- Mohammad Gharehbeglou
Department of Anesthesiology and Critical Care Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications Morteza Hasheminik
Islamic Azad University Sabzevar Branch
2 shared publications
Latest Publications
- 10 May 2025
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 100, 106467
Safety of neuraxial anesthesia in patients with multiple sclerosis: A systematic review of observational evidence
- 10 May 2025
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 100, 106467
Safety of neuraxial anesthesia in patients with multiple sclerosis: A systematic review of observational evidence
- Open Access
- 13 March 2023
- Published by Wiley
Extensive Left Ventricular Thrombosis after Recovery from Covid-19 inpatient how was receiving Aspirin and prophylactic Apixaban
Numerous different complications have been reported following Covid-19 disease.Although the disease often improves after going through various clinical phases,some people have Various complications, including coagulation disorders. The patient is a 59-year-old man who developed extensive heart thrombosis following covid19 involvement a month ago and was hospitalized with extensive cardiac dysrhythmias
- 13 March 2023
- Published by Wiley
Open AccessExtensive Left Ventricular Thrombosis after Recovery from Covid-19 inpatient how was receiving Aspirin and prophylactic Apixaban
Numerous different complications have been reported following Covid-19 disease.Although the disease often improves after going through various clinical phases,some people have Various complications, including coagulation disorders. The patient is a 59-year-old man who developed extensive heart thrombosis following covid19 involvement a month ago and was hospitalized with extensive cardiac dysrhythmias
- Open Access
- 1 December 2022
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 11 (12) , 7957-7959
Rapid spread and high mortality due to community-acquired pneumonia caused by Acinetobacter baumannii (CAP-AB) in a Covid-19 intensive care unit
Acinetobacter baumannii is a rare but dangerous gram-negative bacteria causing nosocomial infections, especially in intensive care units. The increased use of antibiotics in the treatment of bacterial infections leads to drug resistance, delays, or failures in treatment. The patient is a 48-year-old man with coronavirus disease (COVID-19) being treated in the intensive care unit. After contracting Acinetobacter baumannii , the patient’s condition deteriorated, and he developed severe pulmonary problems. Due to the unknown presence of Acinetobacter baumannii in the patient, this bacterium transmitted to six other patients in the ward, which resulted in their deaths. In this report, we describe the causes and risk factors of the disease, and the results of laboratory tests and therapeutic processes.
- 1 December 2022
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 11 (12) , 7957-7959
Open AccessRapid spread and high mortality due to community-acquired pneumonia caused by Acinetobacter baumannii (CAP-AB) in a Covid-19 intensive care unit
Acinetobacter baumannii is a rare but dangerous gram-negative bacteria causing nosocomial infections, especially in intensive care units. The increased use of antibiotics in the treatment of bacterial infections leads to drug resistance, delays, or failures in treatment. The patient is a 48-year-old man with coronavirus disease (COVID-19) being treated in the intensive care unit. After contracting Acinetobacter baumannii , the patient’s condition deteriorated, and he developed severe pulmonary problems. Due to the unknown presence of Acinetobacter baumannii in the patient, this bacterium transmitted to six other patients in the ward, which resulted in their deaths. In this report, we describe the causes and risk factors of the disease, and the results of laboratory tests and therapeutic processes.
- Open Access
- 8 September 2022
- Published by PAGEPress Publications in European Journal of Translational Myology
- Vol. 33 (1)
Promethazine hydrochloride reduces children’s agitation during ocular examination for trauma
Examination and intervention are always the causes of agitation, anxiety, and fear in children’s lives. This study aimed to investigate the effectiveness of promethazine hydrochloride in reducing children’s agitation during the ocular examination for trauma. In this interventional-clinical trial study, a total of 62 children referred to Al-Zahra Ophthalmology Hospital in Zahedan, Iran, were evaluated in two matched groups (case (n = 31) and control (n = 31)) for an initial examination of ocular trauma. Finally, the intervention was performed (giving placebo or promethazine hydrochloride cough syrup 20 minutes before the initial ocular examination at 0.5 mg/kg), and the demographic information form and researcher-made questionnaire modeled on the Cohen-Mansfield Agitation Inventory (CMAI) were completed. The obtained results revealed that the mean scores of physical/aggressive behaviors (p ˂ 0.001), physical/nonaggressive behaviors (p = 0.013), verbal/aggressive behaviors (p ˂ 0.001), and hiding behaviors (p ˂ 0.001) were significantly lower in the promethazine hydrochloride-receiving group than the placebo group. These findings demonstrated that promethazine hydrochloride cough syrup facilitated the examination among the pediatric patients who suffered from traumatic ocular injuries. However, further studies in this field need to be carried out through randomized controlled trials.
- 8 September 2022
- Published by PAGEPress Publications in European Journal of Translational Myology
- Vol. 33 (1)
Open AccessPromethazine hydrochloride reduces children’s agitation during ocular examination for trauma
Examination and intervention are always the causes of agitation, anxiety, and fear in children’s lives. This study aimed to investigate the effectiveness of promethazine hydrochloride in reducing children’s agitation during the ocular examination for trauma. In this interventional-clinical trial study, a total of 62 children referred to Al-Zahra Ophthalmology Hospital in Zahedan, Iran, were evaluated in two matched groups (case (n = 31) and control (n = 31)) for an initial examination of ocular trauma. Finally, the intervention was performed (giving placebo or promethazine hydrochloride cough syrup 20 minutes before the initial ocular examination at 0.5 mg/kg), and the demographic information form and researcher-made questionnaire modeled on the Cohen-Mansfield Agitation Inventory (CMAI) were completed. The obtained results revealed that the mean scores of physical/aggressive behaviors (p ˂ 0.001), physical/nonaggressive behaviors (p = 0.013), verbal/aggressive behaviors (p ˂ 0.001), and hiding behaviors (p ˂ 0.001) were significantly lower in the promethazine hydrochloride-receiving group than the placebo group. These findings demonstrated that promethazine hydrochloride cough syrup facilitated the examination among the pediatric patients who suffered from traumatic ocular injuries. However, further studies in this field need to be carried out through randomized controlled trials.
- Open Access
- 5 July 2022
- Published by PAGEPress Publications in European Journal of Translational Myology
- Vol. 32 (3)
Magnesium supplementation and insulin resistance in patients with rheumatoid arthritis
Rheumatoid arthritis (RA) is a multifactorial disease affecting the immune system and many tissues in the body. This study aimed to evaluate the effect of magnesium supplementation on insulin resistance and fasting blood sugar (FBS) of patients with RA. In this prospective uncontrolled before-after study, RA patients referring to Rheumatology clinics of Qom City from January 2020 to January 2021 were evaluated. First, the patients received the routine rheumatoid arthritis treatment including 5 mg Prednisolone and 200mg Hydroxychloroquine daily for 6 months and FBS and insulin levels were measured after. Then, they received the routine arthritis rheumatoid treatment in addition to 300 mg/day oral Magnesium sulfate for 6 months and then, FBS and insulin levels were measured. The Homeostasis Model Assessment of insulin resistance (HOMA-IR) was used for determining insulin resistance. Thirty five patients with RA and the mean age of 49.83±2.58 years were enrolled. Twenty eight cases (80%) were female and 7 cases (20%) were male. The mean HOMA-IR before and after consumption of oral magnesium were 3.04±0.29 and 2.43±0.19, respectively. Statistically significant differences were found between FBS, insulin and HOMA-IR before and after consumption of oral magnesium (p<0.05). Our data suggested that magnesium supplementation reduces FBS, insulin and HOMA-IR in patients with rheumatoid arthritis. Thus, magnesium supplements may be an alternative method for prevention of type 2 diabetes in RA patients.
- 5 July 2022
- Published by PAGEPress Publications in European Journal of Translational Myology
- Vol. 32 (3)
Open AccessMagnesium supplementation and insulin resistance in patients with rheumatoid arthritis
Rheumatoid arthritis (RA) is a multifactorial disease affecting the immune system and many tissues in the body. This study aimed to evaluate the effect of magnesium supplementation on insulin resistance and fasting blood sugar (FBS) of patients with RA. In this prospective uncontrolled before-after study, RA patients referring to Rheumatology clinics of Qom City from January 2020 to January 2021 were evaluated. First, the patients received the routine rheumatoid arthritis treatment including 5 mg Prednisolone and 200mg Hydroxychloroquine daily for 6 months and FBS and insulin levels were measured after. Then, they received the routine arthritis rheumatoid treatment in addition to 300 mg/day oral Magnesium sulfate for 6 months and then, FBS and insulin levels were measured. The Homeostasis Model Assessment of insulin resistance (HOMA-IR) was used for determining insulin resistance. Thirty five patients with RA and the mean age of 49.83±2.58 years were enrolled. Twenty eight cases (80%) were female and 7 cases (20%) were male. The mean HOMA-IR before and after consumption of oral magnesium were 3.04±0.29 and 2.43±0.19, respectively. Statistically significant differences were found between FBS, insulin and HOMA-IR before and after consumption of oral magnesium (p<0.05). Our data suggested that magnesium supplementation reduces FBS, insulin and HOMA-IR in patients with rheumatoid arthritis. Thus, magnesium supplements may be an alternative method for prevention of type 2 diabetes in RA patients.
- Open Access
- Vol. 24 (1) , 78-87
The Effect of Intermittent Use of Oxygen Therapy via High-Flow Nasal Cannula Alternating with Noninvasive Ventilation on Critically Ill Patients
Despite limited research on high-flow nasal cannula (HFNC) alternating with noninvasive ventilation (NIV), this study investigates its effect on intensive care unit (ICU) patients. This clinical trial study at Masih Deneshvari Hospital (Tehran) compared NIV vs. alternating NIV with HFNC for ICU patients. It assessed intubation, mortality, and vitals. Patients were informed, and nurses were trained for optimal care. Daily follow-up ensured data collection. The mean age of the patients was 66.3±19.7 years, which was 67.1±14.8 years in the NIV group and 65.5±14.9 years in the HFNC+NIV group, respectively. The distribution of patients in terms of APACHE and symptoms showed no significant difference (P=0.453). The mean HR in the two groups, NIV and HFNC+NIV, before the study was 113.30±5.25 and 112.43±5.80, respectively. At the end of the study, it was 94.78±17.53 and 94.48±17.47, respectively, with no significant difference found between the two groups. The mean RR before the beginning of this study was not significantly different between the two groups, while it was 16.61±4.23 and 17.91±1.78 in the NIV and HFNC+NIV groups, respectively, at the end of the study (P=0.043). PO2 created a greater distinction between the two groups based on the decision tree analysis, where the NIV group was more likely to have values of PO2<70. Based on the findings presented in our study, no difference was found between the use of NIV and NIV + HFNC, but HFNC + NIV was a more tolerable technique for patients.
- Vol. 24 (1) , 78-87
Open AccessThe Effect of Intermittent Use of Oxygen Therapy via High-Flow Nasal Cannula Alternating with Noninvasive Ventilation on Critically Ill Patients
Despite limited research on high-flow nasal cannula (HFNC) alternating with noninvasive ventilation (NIV), this study investigates its effect on intensive care unit (ICU) patients. This clinical trial study at Masih Deneshvari Hospital (Tehran) compared NIV vs. alternating NIV with HFNC for ICU patients. It assessed intubation, mortality, and vitals. Patients were informed, and nurses were trained for optimal care. Daily follow-up ensured data collection. The mean age of the patients was 66.3±19.7 years, which was 67.1±14.8 years in the NIV group and 65.5±14.9 years in the HFNC+NIV group, respectively. The distribution of patients in terms of APACHE and symptoms showed no significant difference (P=0.453). The mean HR in the two groups, NIV and HFNC+NIV, before the study was 113.30±5.25 and 112.43±5.80, respectively. At the end of the study, it was 94.78±17.53 and 94.48±17.47, respectively, with no significant difference found between the two groups. The mean RR before the beginning of this study was not significantly different between the two groups, while it was 16.61±4.23 and 17.91±1.78 in the NIV and HFNC+NIV groups, respectively, at the end of the study (P=0.043). PO2 created a greater distinction between the two groups based on the decision tree analysis, where the NIV group was more likely to have values of PO2<70. Based on the findings presented in our study, no difference was found between the use of NIV and NIV + HFNC, but HFNC + NIV was a more tolerable technique for patients.